全文获取类型
收费全文 | 102244篇 |
免费 | 7725篇 |
国内免费 | 4929篇 |
专业分类
耳鼻咽喉 | 463篇 |
儿科学 | 2352篇 |
妇产科学 | 612篇 |
基础医学 | 8809篇 |
口腔科学 | 674篇 |
临床医学 | 12831篇 |
内科学 | 8558篇 |
皮肤病学 | 305篇 |
神经病学 | 18787篇 |
特种医学 | 6691篇 |
外国民族医学 | 7篇 |
外科学 | 15640篇 |
综合类 | 17046篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 4647篇 |
眼科学 | 967篇 |
药学 | 9268篇 |
45篇 | |
中国医学 | 4159篇 |
肿瘤学 | 3032篇 |
出版年
2024年 | 361篇 |
2023年 | 1692篇 |
2022年 | 2990篇 |
2021年 | 4246篇 |
2020年 | 3857篇 |
2019年 | 3170篇 |
2018年 | 3118篇 |
2017年 | 3501篇 |
2016年 | 3683篇 |
2015年 | 3637篇 |
2014年 | 6211篇 |
2013年 | 7449篇 |
2012年 | 5903篇 |
2011年 | 6409篇 |
2010年 | 5537篇 |
2009年 | 5213篇 |
2008年 | 5295篇 |
2007年 | 5334篇 |
2006年 | 5035篇 |
2005年 | 4414篇 |
2004年 | 3512篇 |
2003年 | 3256篇 |
2002年 | 2669篇 |
2001年 | 2368篇 |
2000年 | 1913篇 |
1999年 | 1650篇 |
1998年 | 1444篇 |
1997年 | 1453篇 |
1996年 | 1174篇 |
1995年 | 973篇 |
1994年 | 885篇 |
1993年 | 669篇 |
1992年 | 628篇 |
1991年 | 498篇 |
1990年 | 459篇 |
1989年 | 417篇 |
1988年 | 385篇 |
1987年 | 335篇 |
1986年 | 386篇 |
1985年 | 477篇 |
1984年 | 444篇 |
1983年 | 289篇 |
1982年 | 357篇 |
1981年 | 318篇 |
1980年 | 289篇 |
1979年 | 160篇 |
1978年 | 104篇 |
1977年 | 90篇 |
1976年 | 86篇 |
1975年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
H. Inaba M.D. J. Sato H. Uchida M. Sakurada T. Ohwada T. Mizuguchi 《Acta anaesthesiologica Scandinavica》1988,32(5):374-378
Fluctuating PEEP (F-PEEP) is a newly developed PEEP in which end-expiratory pressure (EEP) is periodically changed within a certain range. In a dog model with unilateral lung injury induced by the introduction of hydrochloric acid, F-PEEP in which the EEP was periodically changed from 0.5 to 1.5 kPa at periods of 6 min, and conventional PEEP (C-PEEP) with an optimized EEP of 1.0 kPa, were each applied for 30 min. F-PEEP produced a significantly greater improvement of PaO2 and intrapulmonary shunt (QS/QT) than C-PEEP, and at the low EEP phase, the greatest improvement accompanied by an increased dynamic compliance and a large cardiac output was obtained. These results suggest that F-PEEP provides a useful mode of artificial ventilation for the treatment of unilateral lung injury. 相似文献
52.
53.
54.
55.
Sources of P300 attenuation after head injury: Single-trial amplitude, latency jitter, and EEG power
Single trial amplitude, latency jitter, and electroencephalographic (EEG) power were examined as sources of the group difference in averaged P300 amplitude among 15 traumatically brain injured and 20 control individuals in an auditory oddball paradigm. Mean amplitude of the individual trials was highly correlated with the amplitude of the averaged P300, with little additional unique variance attributable to latency jitter or EEG power. The group difference in P300 amplitude was also explained by the mean amplitude of the single trials. These results support the robustness of the event-related potential averaging technique within the paradigm used. 相似文献
56.
狗脊髓截除自体隐神经大网膜移植的初步观察 总被引:3,自引:0,他引:3
实验用6只狗于T13处切除脊髓8mm,局部用隐神经、大网膜移植。对照组6只狗单纯切除脊髓8mm。术后3个月、6个月实验组动物全部恢复到C/Ⅲ级功能,组织学切片见移植神经有不同程度存活,可记录到股四头肌、胫前肌电位。对照组动物仅达到0/0~A/I织功能,组织学切片见脊髓缺损处为结缔组织,诱电位波形消失。分析了影响脊髓神经功能恢复的原因。 相似文献
57.
神经移位修复臂丛神经根性撕脱伤 总被引:3,自引:2,他引:1
1987年7月~1994年6月,对21例臂丛神经根性撕脱伤采用神经移位修复。其中复合移位4组神经(膈神经、副神经、颈丛运动支、肋间神经)者1例,3组(膈神经、副神经、颈丛运动支)者6例,2组(膈神经、副神经)者9例,1组(膈神经或颈丛运动支或肋间神经)者5例。术中发现臂丛神经变异1例,对4例合并锁骨下动脉损伤者,在神经移位的同时进行血管修复,促进患肢的血液循环,有利于神经的康复。随访到19例,随访时间为8个月~6年2个月,优良率达73.7%。认为,神经移位术是修复神经根性撕裂伤的常规方法,合并血管损伤者也应同时修复,对促进神经功能恢复有利 相似文献
58.
刘达恩 《中国修复重建外科杂志》1997,11(2):83-85
总结胸腹轴型皮瓣早期修复上肢不同部位的深度蛇伤溃疡的经验,评价其应用价值。本组16例,胸脐皮瓣2例,侧胸腹皮瓣1例,髂腰皮瓣5例,下腹皮瓣6例,下腹分叶皮瓣1例,髂腰加下腹Y形皮瓣1例。术后1例皮瓣远端坏死,3例轻度感染,16例断蒂后全部成活。随访3个月~7年,皮瓣质地和弹性均好,手功能基本恢复。认为,带蒂胸腹轴型皮瓣是修复上肢深度蛇伤溃疡理想的方法。 相似文献
59.
Patrick M. Rao M.D. A. John Kuta M.D. Michele H. Johnson M.D. 《Emergency radiology》1995,2(5):303-304
We present a case in which an open fracture of the ulna penetrated the skull and caused a comminuted, depressed skull fracture
with a large intraparenchymal hematoma containing bone fragments. 相似文献
60.
3-Methoxytyramine (3-MT) is a minor metabolite of dopamine which is suggested to reflect the turnover and utilization of dopamine. A novel, isocratic HPLC method has been developed which can be used to analyse 3-MT in homogenates of rat brain without the need for additional purification procedures. Furthermore, the coulometric electrochemical detection system is sensitive enough to measure 3 pg of 3-MT (equivalent to 0.6 ng/g tissue wet weight). 3-Methoxytyramine was measured in the striatum and n. accumbens after decapitation and rapid freezing, using 3-methoxy-4-hydroxybenzylamine as the internal standard. The effects of dopaminergic and other drugs on this metabolite were examined using this method. -Methyl-p-tyrosine (200 mg/kg i.v.) produced parallel linear decreases in dopamine and 3-MT in naive rats, but not those pretreated with tranylcypromine (5 mg/kg i.p.). Methamphetamine (0.3–10 mg/kg i.p.) and amphetamine (0.3–10 mg/kg i.p.) both dose-dependently increased 3-MT in naive and tranylcypromine-pretreated rats. In naive animals, 3-MT was not altered by intraperitoneal injection of the dopamine reuptake inhibitors, bupropion (10 mg/kg) and nomifensine (10 mg/kg) or by sibutramine HCl (3 mg/kg), amitriptyline (10 mg/kg), desipramine (10 mg/kg) and zimeldine (10 mg/kg). 3-Methoxy-tyramine was decreased by apomorphine (5 mg/kg i.p.) and also by large doses of the selective D2 antagonist, BRL 34778 (5 mg/kg i.p.) or
-DOPA (50 mg/kg i.p.). The selective D1 antagonist, SCH 23390 (0.1 or 5 mg/kg i.p.) was without effect. In tranylcypromine-pretreated rats, 3-MT was dose-dependently reduced and increased by apomorphine (0.01–5 mg/kg i.p.) and BRL 34778 (0.1–5 mg/kg i.p.), respectively. The drug SCH 23390 (0.1–5 mg/kg i.p.) produced much smaller increases in 3-MT which were probably mediated through the striatonigral pathway. Overall, the data suggest that measurement of 3-MT, after inhibition of monoamine oxidase, is a useful index of the release and utilization of dopamine. However, after substantial and prolonged depletion of dopamine, levels of 3-MT in naive animals are a better index. Also, the formation of 3-MT in naive rats provides a sensitive method for distinguishing between dopamine releasing agents and reuptake inhibitors. 相似文献